Generali Investments Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Hold
782
0.07% 133
2026
Q1
$229K Sell
782
-290
-27% -$95.3K 0.05% 129
2025
Q4
$376K Sell
1,072
-950
-47% -$321K 0.07% 115
2025
Q3
$653K Hold
2,022
0.14% 103
2025
Q2
$785K Sell
2,022
-469
-19% -$189K 0.18% 95
2025
Q1
$1.08M Buy
2,491
+688
+38% +$276K 0.31% 75
2024
Q4
$665K Buy
+1,803
New +$754K 0.17% 85

Other funds holding ELV

Generali Investments Management's ELV Position: Q2 2026 in Review

Generali Investments Management held its Elevance Health (ELV) position steady in Q2 2026 at 782 shares worth $302K. The position accounts for 0.07% of the portfolio, ranked #133.

Generali Investments Management first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.08M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Generali Investments Management held 782 shares of Elevance Health worth $302K as of Q2 2026.
  • Generali Investments Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.07% of Generali Investments Management's portfolio in Q2 2026, its #133 holding.
  • Generali Investments Management first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments Management's Elevance Health position peaked at $1.08M in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.